TCIM
ALBO

TIAA CREF Investment Management’s Albireo Pharma Inc ALBO Stock Holding History

TIAA CREF Investment Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$572K Buy
17,751
+98
+0.6% +$2.64K ﹤0.01% 2545
2018
Q4 		$433K Sell
17,653
-236
-1% -$6.24K ﹤0.01% 2626
2018
Q3 		$590K Sell
17,889
-8,248
-32% -$270K ﹤0.01% 2652
2018
Q2 		$928K Buy
+26,137
New +$847K ﹤0.01% 2522

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

TIAA CREF Investment Management's ALBO Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Albireo Pharma Inc (ALBO) stake by 0.56% in Q1 2019, buying an estimated $2.64K and bringing the position to 17,751 shares worth $572K. The position accounts for ﹤0.01% of the portfolio, ranked #2545.

TIAA CREF Investment Management first reported a position in ALBO in Q2 2018 and has held it in 4 quarters since. The position peaked at $928K in Q2 2018. 72 funds tracked by Wall St. Rank hold ALBO as of Q1 2019.

  • TIAA CREF Investment Management held 17,751 shares of Albireo Pharma Inc worth $572K as of Q1 2019.
  • TIAA CREF Investment Management bought 98 Albireo Pharma Inc shares in Q1 2019, an estimated $2.64K.
  • Albireo Pharma Inc made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2545 holding.
  • TIAA CREF Investment Management first reported a position in Albireo Pharma Inc in Q2 2018 and has held it in 4 quarters since.
  • TIAA CREF Investment Management's Albireo Pharma Inc position peaked at $928K in Q2 2018.
  • 72 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.